Sign inJoin waitlistJoin the waitlist

Candace Mainor

Physician · MedStar Health

Credentials: · · · ·

History

MedStar Health
2025–Present

University of Maryland, Baltimore
2015–2017
Internal Medicine
2012–2015
University of Maryland School of Medicine
2008–2012

Research

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Nature Communications · 2024 · Co-first of 29 authors · 31 citations
Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection
Lung Cancer · 2018 · 12 citations
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease
Journal of Clinical Oncology · 2026 · 9 citations

Claudine Isaacs
11 papers
Filipa Lynce
7 papers
Paula Pohlmann
7 papers
SS
Sandra Swain
5 papers
Ami Chitalia
4 papers
CG
Christopher Gallagher
4 papers
Ilana Schlam
4 papers · 4 as a fellow
JC
Julie Collins
4 papers
Rita Nanda
4 papers
ST
Shruti Tiwari
4 papers
Deena Graham
3 papers
Erica Stringer-Reasor
3 papers

Clinical trials

RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
Principal investigator · Recruiting · Phase 1, Phase 2
Georgetown University
2023–2026
Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery
Principal investigator · Terminated · Phase 2
Georgetown University
2018–2023
OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease
Study chair · Completed · Phase 2
Georgetown University
2018–2024